Notice of Closed Meeting, 2921 [2023-00783]
Download as PDF
<![CDATA[
Federal Register / Vol. 88, No. 11 / Wednesday, January 18, 2023 / Notices
2921
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Form name
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hours)
...........................................................
........................
........................
........................
Type of respondents
Total ...........................................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2023–00809 Filed 1–17–23; 8:45 am]
BILLING CODE 4163–18–P
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[FR Doc. 2023–00783 Filed 1–17–23; 8:45 am]
BILLING CODE 4163–18–P
lotter on DSK11XQN23PROD with NOTICES1
Notice of Closed Meeting
Pursuant to section 1009(d) of 5
U.S.C. 10, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 117–286. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
RFA–TS–23–001: Identify and Evaluate
Potential Risk Factors for Amyotrophic
Lateral Sclerosis (ALS).
Date: March 21, 2023.
Time: 8:30 a.m.–5:30 p.m., EDT.
Place: Videoconference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact:
Carlisha Gentles, PharmD, BCPS,
CDCES, Scientific Review Officer,
National Center for Injury Prevention
and Control, CDC, 4770 Buford Highway
NE, Mailstop F–63, Atlanta, Georgia
30341; Telephone: (770) 488–1504;
Email: CGentles@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
VerDate Sep<11>2014
17:41 Jan 17, 2023
Jkt 259001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–23–23BX; Docket No. CDC–2022–
0144]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing efforts to reduce public
burden and maximize the utility of
government information, invites the
general public and other federal
agencies to take this opportunity to
comment on a proposed information
collection, as required by the Paperwork
Reduction Act of 1995. This notice
invites comment on a new proposed
information collection project titled PreShift Lighting Interventions to Improve
Miner Safety and Well-Being. The
purpose of this information collection is
to examine the effect of human centric
lighting (HCL) interventions on
circadian disruption (CD) and wellbeing in underground mineworkers.
DATES: Written comments must be
received on or before March 20, 2023.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2022–
0144 by any of the following methods:
• Federal eRulemaking Portal:
www.regulations.gov. Follow the
instructions for submitting comments.
SUMMARY:
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
Total burden
(in hours)
250
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
www.regulations.gov.
Please note: Submit all comments through
the Federal eRulemaking portal
(www.regulations.gov) or by U.S. mail to the
address listed above.
To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329;
Telephone: 404–639–7118; Email: omb@
cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
FOR FURTHER INFORMATION CONTACT:
E:\FR\FM\18JAN1.SGM
18JAN1
]]>Agencies
[Federal Register Volume 88, Number 11 (Wednesday, January 18, 2023)]
[Notices]
[Page 2921]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-00783]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Closed Meeting
Pursuant to section 1009(d) of 5 U.S.C. 10, notice is hereby given
of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended, and the Determination of the Director, Strategic
Business Initiatives Unit, Office of the Chief Operating Officer, CDC,
pursuant to Public Law 117-286. The grant applications and the
discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: Disease, Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)--RFA-TS-23-001: Identify and
Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis
(ALS).
Date: March 21, 2023.
Time: 8:30 a.m.-5:30 p.m., EDT.
Place: Videoconference.
Agenda: To review and evaluate grant applications.
For Further Information Contact: Carlisha Gentles, PharmD, BCPS,
CDCES, Scientific Review Officer, National Center for Injury Prevention
and Control, CDC, 4770 Buford Highway NE, Mailstop F-63, Atlanta,
Georgia 30341; Telephone: (770) 488-1504; Email: [email protected].
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-00783 Filed 1-17-23; 8:45 am]
BILLING CODE 4163-18-P
